ContractDevelopment and Supply Agreement • August 8th, 2008 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances)
Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.
AMENDMENT No. 1 to Collaboration and License AgreementCollaboration and License Agreement • August 8th, 2008 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York
This AMENDMENT No. 1 to Collaboration and License Agreement (the “Amendment”), effective as of May 15, 2008 (the “Amendment Date”), is entered into by and between BAYER Healthcare AG, a German corporation, having its principal place of business at D-51368, Leverkusen, Germany, (“Licensee”), and Seattle Genetics, Inc., a Delaware corporation with an office at 21823 30th Drive S.E., Bothell, WA 98021 (“Licensor”).
